Latest News & Features
Big Pharma
Pfizer has apologised to UK-based healthcare providers for any confusion or increased workload following the English High Court’s decision on a patent infringement case centring on its epilepsy drug Lyrica. 9 June 2015
Americas
Hedge fund manager Kyle Bass has filed another petition for an inter partes review of a patent covering Horizon Pharma’s arthritis drug Vimovo. 9 June 2015
Big Pharma
The English High Court has ordered Novartis to pay 75% of the defendants’ legal costs in a patent infringement case against Focus Pharmaceuticals, Actavis and Teva. 8 June 2015
Americas
The US Court of Appeals for the Federal Circuit has heard oral arguments in Amgen v Sandoz, a case that should determine whether it is mandatory for biosimilar applicants to engage in the so-called patent dance. 8 June 2015
Americas
The Biotechnology Industry Organization has supported potential amendments to the Protect American Talent and Entrepreneurship Act, which was approved by the Senate Judiciary Committee yesterday. 5 June 2015
Americas
US law firm Taylor English has added Kelly Mullally to its intellectual property practice in Atlanta. 5 June 2015
Americas
California-based pharmaceutical company Prometheus Laboratories has asked the US Court of Appeals for the Federal Circuit to reinstate a patent covering its irritable bowel syndrome drug Lotronex. 4 June 2015
Americas
Robert Licht, former senior vice president of pharmaceutical company Biogen, has joined law firm Choate Hall & Stewart as a partner in the firm’s life sciences group. 4 June 2015
Asia
The Indian Patent Office has reportedly rejected an application covering US company Abraxis BioScience’s cancer drug Abraxane. 3 June 2015
Americas
Novartis has sued Apotex at the US District Court for the District of New Jersey to protect its drug Zometa from generic competition. 2 June 2015